One study showed that sodium butyrate affects proliferation and migration of A549 cells by activating the TNF receptor-associated factor 6 (TRAF6)-thioredoxin-interacting protein (TXNIP) pathway, suggesting that sodium butyrate has an effective therapeutic effect on lung adenocarcinoma. Here, TXNIP is linked to lung adenocarcinoma.